FWM
GMED icon

Filbrandt Wealth Management’s Globus Medical GMED Stock Holding History

Filbrandt Wealth Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-50
Closed -$2K – 235
2020
Q2 		$2K Buy
+50
New +$2.41K ﹤0.01% 318

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Filbrandt Wealth Management's GMED Position: Q3 2020 in Review

Filbrandt Wealth Management sold out of Globus Medical (GMED) in Q3 2020, closing a stake of 50 shares — an estimated $2K sold.

Filbrandt Wealth Management first reported a position in GMED in Q2 2020 and held it in 1 quarter. The position peaked at $2K in Q2 2020. 344 funds tracked by Wall St. Rank hold GMED as of Q3 2020.

  • Filbrandt Wealth Management reported no remaining Globus Medical position as of Q3 2020 after selling out during the quarter.
  • Filbrandt Wealth Management sold 50 Globus Medical shares in Q3 2020, an estimated $2K.
  • Filbrandt Wealth Management first reported a position in Globus Medical in Q2 2020 and held it in 1 quarter.
  • Filbrandt Wealth Management's Globus Medical position peaked at $2K in Q2 2020.
  • 344 funds tracked by Wall St. Rank held Globus Medical as of Q3 2020.

Based on Filbrandt Wealth Management's 13F filing for Q3 2020, filed 29 Oct 2020.